2.84

2.84 (-1.07%)

As of Feb 20, 2024

Armata Pharmaceuticals, Inc. [ARMP]

Source: 

Company Overview

We are a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using our proprietary bacteriophage-based technology. Bacteriophages or phages have a powerful and highly differentiated mechanism of action that enables binding to and killing specific bacteria, in contrast to traditional broad-spectrum antibiotics.

CountryUS
Headquartersmarina del reycalifornia
Phone Number(310) 665-2928
Industrybiological products (no diagnostic substances)
CEOBrian Varnum, Ph.D.
Websitearmatapharma.com

Recent Stories